The conversation highlights the unique investment strategies employed at Memorial Sloan Kettering, emphasizing a strong commitment to funding rare cancer research. Insights into Jason's due diligence process, including 30 key questions and a pre-mortem analysis, provide valuable tools for effective capital allocation. The discussion also touches on the emotional connection to the mission, underscoring the importance of purpose-driven investing.
